Feb. 12, 2021
MU Research Reactor to supply radioisotope for targeted cancer therapy
The University of Missouri Research Reactor (MURR®) has entered into an exclusive multi-year agreement with Advanced Accelerator Applications International to provide a key ingredient in a targeted therapy for certain types of cancerous tumors.
Feb. 3, 2021
Probiotics or prebiotics? Exploring the complex world of ‘gut’ health
University of Missouri researchers develop a noninvasive way for identifying the major functions of the gastrointestinal tract.
Jan. 27, 2021
President Choi's testimony to legislators details university’s vast impact on Missouri
Funding for UM's core budget, NextGen Precision Health is critical for education, research and outreach
Jan. 25, 2021
MU Research Reactor to supply radioisotope for targeted cancer therapy
Jan. 12, 2021
Killing cancer by unleashing the body’s own immune system
University of Missouri scientists demonstrate a new bacteria-based strategy for turning the body’s own immune system against cancer.
Dec. 14, 2020
NextGen Precision Health brings together researchers from across the UM System
A December 2020 project update from Richard Barohn, executive director of NextGen Precision Health.
Nov. 19, 2020
Former UM System president gives $2 million to NextGen Data Science and Analytics Innovation Center at UMKC
Gift supports a collaborative effort between UMKC and MU housed in Kansas City.
Oct. 9, 2020
Establishing Mizzou as a national leader in precision health
As executive vice chancellor for health affairs, Rick Barohn is using his talent for inspiring others to put Mizzou at the forefront of life-changing precision health advancements.
Sep. 23, 2020
Leading the way
MU researcher Salman Hyder has spent a career battling breast cancer and mentoring the next generation of researchers.
Aug. 26, 2020
Placenta can indicate how body responds to opioids during pregnancy
MU scientists discover possible biological markers for identifying opioid use disorder.